Effectiveness of combination therapy with liposomal amphotericin B and miltefosine for visceral leishmaniasis in HIV coinfection: DNDi/MSF strategy for policy change in East Africa
Effectiveness of combination therapy with liposomal amphotericin B and miltefosine for visceral leishmaniasis in HIV coinfection: DNDi/MSF strategy for policy change in East Africa | Conference Material / Slide Presentation | MSF Science Portal